Health Catalyst, Inc. (HCAT) |
| 2.15 0.07 (3.37%) 07-27 16:00 |
| Open: | 2.1 |
| High: | 2.18 |
| Low: | 2.1 |
| Volume: | 368,178 |
| Market Cap: | 159(M) |
| PE Ratio: | 10.75 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 2.79 |
| Resistance 1: | 2.39 |
| Pivot price: | 2.20 |
| Support 1: | 1.93 |
| Support 2: | 1.64 |
| 52w High: | 4.115 |
| 52w Low: | 0.955 |
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
| EPS | -3.730 |
| Book Value | 1.870 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.065 |
| Profit Margin (%) | -87.70 |
| Operating Margin (%) | -9.54 |
| Return on Assets (ttm) | -3.5 |
| Return on Equity (ttm) | -103.0 |
Mon, 27 Jul 2026
Health Catalyst Inc (HCAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fri, 24 Jul 2026
Health Catalyst Inc (HCAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Fri, 24 Jul 2026
HCAT|Health Catalyst Inc|Price:2.025|Chg%:+0.015 - TradingKey
Tue, 21 Jul 2026
Impax Asset Management Group (HCAT) discloses 4M-share position in Health Catalyst - Stock Titan
Mon, 20 Jul 2026
Health Catalyst (HCAT) awards 80,691 restricted stock units to company director - Stock Titan
Wed, 15 Jul 2026
3 Reasons to Sell HCAT and 1 Stock to Buy Instead - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |